Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AORT | Common Stock | Award | $0 | +3.77K | +3.22% | $0.00 | 121K | Feb 23, 2023 | Direct | F1 |
transaction | AORT | Common Stock | Sale | -$15.3K | -1.19K | -0.98% | $12.94 | 120K | Feb 27, 2023 | Direct | F2 |
transaction | AORT | Common Stock | Award | $0 | +7.63K | +6.37% | $0.00 | 127K | Feb 23, 2023 | Direct | F3 |
transaction | AORT | Common Stock | Sale | -$15.6K | -1.21K | -0.95% | $12.94 | 126K | Feb 27, 2023 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents performance stock units granted on Feb 23, 2022. Hundred percent (100%) were issued on Feb 23, 2023. |
F2 | These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |
F3 | Represents performance stock units granted on Feb 23, 2022. Fifty percent (50%) were issued on Feb 23, 2023. The remaining shares earned in connection with the Feb 2022 grant will be eligible to vest and be issued as follows: 25% on 02/23/2024, and 25% on 02/23/2025, assuming continued employment on the relevant vesting date. |